Henry C. Nipper, Ph.D., director of clinical chemistry and toxicology in Creighton University’s Department of Pathology, has been appointed to the Substance Abuse and Mental Health Services Administration’s Drug Testing Advisory Board, part of the U.S. Department of Health and Human Services. The Drug Testing Advisory Board makes recommendations to the Substance Abuse and Mental Health Services Administration regarding the direction, scope, balance and emphasis of federal drug testing activities and federal drug testing laboratory certification program. These recommendations are generally followed by state agencies and the private sector for non-federally regulated drug testing.

Dr. Nipper was appointed to serve a four-year term on the board, comprised of individuals and who are recognized as experts in analytical forensic toxicology, specimen collection procedures or interpretation of drug testing results. Dr. Nipper also serves Creighton as associate professor of pathology and assistant dean for admissions in the School of Medicine.